Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr724 Inhibitors

Olr724 inhibitors represent a unique class of chemical compounds primarily recognized for their role in modulating the Olr724 protein, an olfactory receptor within the G-protein coupled receptor (GPCR) superfamily. These inhibitors interact specifically with the Olr724 receptor, which is responsible for detecting certain odorant molecules. By inhibiting the Olr724 receptor, these compounds can effectively alter the signal transduction pathways associated with olfactory perception. The specificity of these inhibitors is critical, as the olfactory system relies on a delicate balance of receptor activity to accurately process and interpret a vast array of odorant molecules. The chemical structure of Olr724 inhibitors often includes specific functional groups that facilitate binding to the receptor's active site, thereby preventing the usual conformational changes required for receptor activation and subsequent signal transduction.

The study of Olr724 inhibitors extends into the broader field of olfactory receptor research, offering insights into the molecular mechanisms governing olfaction. Researchers have employed various methodologies to explore the binding affinities, selectivity, and kinetic properties of these inhibitors. Techniques such as molecular docking, X-ray crystallography, and nuclear magnetic resonance (NMR) spectroscopy are frequently utilized to elucidate the three-dimensional structures and dynamic interactions of Olr724 inhibitors with their target receptors. Additionally, synthetic chemistry approaches have enabled the development of diverse inhibitor analogs, providing a rich source of data on structure-activity relationships (SAR). This wealth of information not only advances our understanding of Olr724 receptor function but also contributes to the broader knowledge of GPCR signaling and regulation, highlighting the intricate interplay between chemical structure and biological function in olfactory systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor, potentially disrupting proteins involved in cell growth and proliferation pathways.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Immunomodulatory agent, potentially affecting proteins in immune response and angiogenesis pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF kinase inhibitor, potentially affecting proteins in RAF/MEK/ERK signaling pathways.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Microtubule stabilizer, potentially disrupting cell division and affecting proteins in the mitotic spindle.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-kinase inhibitor, potentially affecting proteins in angiogenesis and cell proliferation pathways.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Alkylating agent, potentially disrupting DNA replication and cell division processes.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially disrupting multiple signaling pathways.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, potentially disrupting proteins in the MAPK/ERK pathway.